Qian Nian Jian (Homalomena Rhizome)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Qian Nian Jian?

  Roughly 4.5–10 g in decoction — this site records 5–10 g from one published reference and 4.5–9 g from another, which is the same range with different editorial rounding. The part used is the rhizome.

  • No genuine disagreement — the two recorded ranges overlap almost completely; this is convention, not conflict.
  • Dose ceiling matters here — see the toxicity section. This site’s own record documents two reported overdose cases, which makes the upper bound of the range meaningful rather than nominal.
  • Professional supervision — given the overdose reports, this is an herb for prescribed use rather than casual self-administration, and it should not be taken above the recorded range.

  Source: the site’s own dosage record (two published references); cross-referenced against multiple online sources. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Are there cautions for Qian Nian Jian?

  This site’s record lists no traditional contraindications, but it does record two overdose cases — so “no contraindications” should not be read as “no limits.” The meaningful caution for this herb is dose, not patient type.

  • Stay within the dose range — see the toxicity section for what the reported overdose cases involved. The recorded range of roughly 4.5–10 g is the operative boundary, and this is an herb for prescribed rather than casual use.
  • Warm and drying — as an acrid, warm, wind-damp-dispelling herb it is conventionally used carefully where yin is deficient or where there is heat, in line with the general handling of its category. This is a category principle, not a documented contraindication for this herb specifically.
  • Pregnancy — not documented as contraindicated in the sources we could verify. Given the overdose reports, professional guidance is the appropriate route in pregnancy and lactation.
  • Handling the raw rhizome — see the toxicity section. We were not able to establish whether the raw material shares the mucosal irritancy documented for other arum-family rhizomes, and we say so rather than assuming either way.

  Source: the site’s own cautions record (“none noted”) read together with its own toxicity record (two reported overdose cases); general category cautions from published materia medica consensus; cross-referenced against multiple online sources. Reference note, not a safety guarantee.

Chinese Herb Toxicity & Overdose

• Is Qian Nian Jian toxic? Does it contain irritant calcium oxalate crystals like Ban Xia?

  Two things, and they need separating. First, what is documented: this site’s record notes two reported overdose cases, with nausea, vomiting, dizziness, convulsions, loss of consciousness, and urinary and bowel incontinence. That is a real, recorded dose-dependent hazard and it is why the upper end of the dose range matters. Second, the family question: Homalomena occulta is an Araceae rhizome, and irritant calcium-oxalate raphides are well documented in that family — but we could find no study documenting them in this species specifically. We report that as an open question, not as a hazard and not as an all-clear.

  • What is documented for the family — a review of mucosal irritant components in Araceae medicinal plants concluded that needle-shaped calcium oxalate crystals (raphides) are the irritant principle across the family, and that this was confirmed in the group’s own work on raw Pinellia ternata. Analytical work on the isolated raphides of three Araceae medicinals — Pinellia ternata, Pinellia pedatisecta and Typhonium flagelliforme — found the irritation is caused by the needle shape itself rather than by any specific chemical carried on the crystals, and that the traditionally processed forms of P. ternata lose the irritant effect. Similar stinging-crystal work exists for Arisaema.
  • What is not documented — we searched the biomedical literature for calcium oxalate, raphides, mucosal irritancy, contact dermatitis or toxicity studies specific to Homalomena occulta. We found none. The extensive published chemistry of this species is almost entirely sesquiterpenoid isolation work; it does not address crystal content or irritancy at all.
  • How we read that — the family-level finding is strong and consistent, and it would be careless to pretend the botanical relationship is irrelevant. But it would be equally careless to transfer a hazard across a family boundary as though it had been measured here. The three Araceae herbs this site classes as toxic — Ban Xia, Tian Nan Xing and Bai Fu Zi — all belong to genera in which raphide irritancy has been directly studied, and all three are traditionally processed for exactly that reason. Qian Nian Jian is not classed as toxic in this site’s record, is not in a processed-drug category, and has not been studied on this point. The honest position is that the family-level irritancy is an inference for this species, not a finding.
  • What follows practically — nothing changes about the herb’s recorded traditional use. It does mean that a reader should not assume the raw rhizome is safe to handle or chew simply because no irritancy has been reported, and should not assume it is dangerous simply because relatives are. Prepared, prescribed use within the recorded dose range is the framing the evidence supports.

  No restricted-substance listing. This herb is not flagged as toxic or endangered in this site’s record, and we found no restricted-substance listing for it in the sources we could verify.

  Sources: the site’s own toxicity record (the two overdose reports) and its identity records for Ban Xia, Zhi Tian Nan Xing and Bai Fu Zi; PMID 17144475 (review of mucosal irritant components in Araceae plants, raphides as the irritant principle); PMID 24308200, DOI 10.1255/ejms.1224 (raphides of Pinellia ternata, P. pedatisecta and Typhonium flagelliforme; irritation attributed to needle shape, absent after processing); PMID 17966350 (processing mechanism of Pinellia ternata); PMID 15615404 (stinging crystals in Arisaema). The absence of species-level data for Homalomena occulta is our own literature-search finding, reported as an absence and not as a negative result. Neutral reference facts — not preparation or dosing guidance.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Qian Nian Jian. We found no interaction studies, case reports or clinical pharmacokinetic work specific to it.

  One precautionary flag follows from the preclinical literature rather than from any demonstrated interaction: sesquiterpenoids from this rhizome have been shown to suppress COX-2 expression and prostaglandin E2 production in cell models, which is the same enzyme pathway targeted by non-steroidal anti-inflammatory drugs. That is a laboratory mechanism finding in cultured cells, not evidence of an additive clinical effect, and it is stated as awareness rather than as an interaction. Patients taking prescription medication should tell their prescriber about any herbal use.

  Source: precautionary inference only, from PMID 30928195, DOI 10.1016/j.bmcl.2019.03.031 (COX-2 and PGE2 suppression in Raw264.7 cells). No clinical interaction is claimed or demonstrated. Flagged for practitioner confirmation.

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Qian Nian Jian (Homalomena occulta)?

  Yes — an unusually deep and sustained sesquiterpenoid chemistry literature running from the early 1990s to the present, with preclinical work on bone cells and inflammation that maps closely onto the traditional indications. There are no clinical trials. The rhizome’s volatile and non-volatile chemistry is dominated by sesquiterpenoids across an unusual variety of carbon skeletons.

  • Bone-building cells (in vitro) — sesquiterpenoids isolated from the rhizome stimulated proliferation and differentiation of cultured osteoblasts, and the chloroform extract together with one isolated compound stimulated mineralisation. This is the strand that most directly echoes the traditional “strengthens tendons and bones” action, though it is cell-culture work.
  • Bone-resorbing cells (in vitro) — a 2026 study isolated seventeen sesquiterpenoids from the aerial part of the plant and reported that five of them inhibited osteoclast formation by more than 90% at 10 micromolar. Osteoblast stimulation and osteoclast inhibition are the two halves of net bone gain, so the two lines of work are complementary, but both remain at cell-model stage and the second used the aerial part rather than the rhizome.
  • Anti-inflammatory (in vitro) — a phytochemical study of the rhizome yielded nineteen sesquiterpenoids including five newly described compounds; three of them suppressed lipopolysaccharide-induced COX-2 expression and prostaglandin E2 production in cultured macrophages in a dose-dependent way. Other groups have reported nitric-oxide production inhibition from further new sesquiterpenoids.
  • Neurological (in vitro) — four long-chain phenolic acids isolated from the roots inhibited BACE1 (beta-secretase), an enzyme of interest in Alzheimer’s disease research, with IC50 values in the 6–8 micromolar range. An enzyme-assay finding and nothing more.
  • Volatile chemistry — the volatile constituents of the rhizome were characterised as early as 1991, and the complete chloroplast genome of the species was published in 2021, which supports species-level authentication.

  What is missing. There is no clinical trial evidence for the traditional wind-damp indications, no toxicology, and — as discussed in the toxicity section — no study of calcium oxalate content or mucosal irritancy for this species despite its arum-family membership. That last gap is the notable one, given how thoroughly the same question has been studied in related genera.

  All of the above is laboratory and cell-model work. None of it is clinical evidence for the traditional indications.

  Sources: PMID 18649899, DOI 10.1016/j.phytochem.2008.05.023 (sesquiterpenoids and osteoblast proliferation, differentiation and mineralisation); PMID 40498476, DOI 10.1080/14786419.2025.2512565 (sesquiterpenoids and anti-osteoclastogenesis); PMID 30928195, DOI 10.1016/j.bmcl.2019.03.031 (homalomenins A–E; COX-2 and PGE2 suppression); PMID 30398200 (new sesquiterpenoids with nitric oxide production inhibitory activity); PMID 26718734 and PMID 27379497 (further sesquiterpenoids from the rhizomes); PMID 20397233, DOI 10.1002/cbdv.200900280 (BACE1 inhibitory phenolic acids); PMID 17226172 (volatile constituents of the rhizome); PMID 33796723 (complete chloroplast genome). Research context, not a therapeutic claim.

Chinese Herb Notes

• How does Qian Nian Jian differ from the other wind-damp herbs?

  Its distinguishing feature is that it both dispels wind-damp and strengthens the sinews and bones, and that it is warm — which makes it the choice for the chronic, cold, deficient presentation in an older patient rather than an acute one. Comparison below is built from this site’s own identity records.

  • Qian Nian Jian — acrid, bitter, warm; Kidney and Liver. Dispels wind-damp and strengthens tendons and bones; specifically associated with weakness and spasm of the sinews in the elderly.
  • Wu Jia Pi — acrid, bitter, warm; Kidney and Liver. The closest match in this site’s records: same nature, same channels, same dual wind-damp-plus-strengthening role. The two are near neighbours and are used in similar situations.
  • Du Huo — bitter, acrid, warm; Kidney and Bladder. The workhorse of the category for wind-damp pain, with a characteristic emphasis on the lower body and lower back. It does not carry the sinew-and-bone strengthening action.
  • Xi Xian Cao — bitter, cold; Kidney and Liver. The cold member of the group, for wind-damp with heat — the opposite temperature choice to Qian Nian Jian.
  • Hai Feng Teng — acrid, bitter, slightly warm; Liver and Kidney. A stem rather than a rhizome, directed at painful obstruction with joint stiffness; less consolidating.
  • Sang Ji Sheng and Du Zhong — not wind-damp herbs (this site files them as tonifying yin and tonifying yang respectively) but frequently the tonic partners for exactly this clinical picture, since both enter Kidney and Liver and both address weak sinews and bones.

  Practical upshot. Acute wind-damp pain with a strong constitution points elsewhere in the category; chronic pain with weak, spasming sinews in a depleted or elderly patient is where Qian Nian Jian is characteristic. (Traditional differentiation, not treatment advice.)

  Is Qian Nian Jian related to Ban Xia and Tian Nan Xing?

  Botanically yes — all are rhizomes or tubers of the arum family, Araceae — but that family relationship does not carry across to how they are classed or handled. This site records Ban Xia (Pinellia ternata), Tian Nan Xing (Arisaema) and Bai Fu Zi (Typhonium giganteum) as toxic in their nature-and-flavour fields, all three in the phlegm-transforming categories, and all three requiring processing before use. Qian Nian Jian is recorded without any toxic designation, in a different category entirely, and is not a processed drug in the same sense. The family tie is a real botanical fact and worth knowing; it is not, by itself, a safety finding. See the toxicity section, where we take that question seriously and answer it at species level.

  Source: the site’s own records for Qian Nian Jian, Wu Jia Pi, Du Huo, Xi Xian Cao, Hai Feng Teng, Sang Ji Sheng, Du Zhong, Ban Xia, Zhi Tian Nan Xing and Bai Fu Zi; botanical family placement per the recorded pharmaceutical Latin. Cross-referenced against multiple online sources.